# Trade Mark Journal No.2025/039 26 September 2025

## WO0000001862500 (5,42)

Office of origin: United States of America

Date of International Registration:26 February 2025
Date of designation in the UK: 26 February 2025

The mark consists of the literal elements CULLINAN THERAPEUTICS with a stylized wing appearing over the "I" in CULLINAN.

International priority date claimed: 26 August 2024 (United States of America) (98717377)

Class 5
  Pharmaceutical products for the prevention and treatment of cancer and autoimmune disorders; therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders; anti-cancer preparations being anti-cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders and for use in the fields of oncology and immunology.
Class 42
  Pharmaceutical research and development; scientific research and development; medical research and development in the fields of oncology, autoimmunity, and immunology; medical research and development services in the fields of drug discovery and oncology, autoimmunity, and immunology.

Cullinan Therapeutics, Inc.

Representative: Christina M. Licursi Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210-2206, UNITED STATES OF AMERICA